Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

NYSE:LION - New York Stock Exchange, Inc. - CA53626N1024 - Common Stock - Currency: USD

6.4  -0.01 (-0.16%)

After market: 6.4 0 (0%)

Fundamental Rating

2

Overall LION gets a fundamental rating of 2 out of 10. We evaluated LION against 72 industry peers in the Entertainment industry. LION has a bad profitability rating. Also its financial health evaluation is rather negative. LION has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year LION was profitable.
LION had a negative operating cash flow in the past year.
In multiple years LION reported negative net income over the last 5 years.
LION had a negative operating cash flow in each of the past 5 years.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of LION (-2.70%) is comparable to the rest of the industry.
LION has a better Return On Invested Capital (4.15%) than 70.83% of its industry peers.
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROIC 4.15%
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

With a decent Operating Margin value of 5.41%, LION is doing good in the industry, outperforming 70.83% of the companies in the same industry.
LION has a Gross Margin of 117.71%. This is amongst the best in the industry. LION outperforms 100.00% of its industry peers.
Industry RankSector Rank
OM 5.41%
PM (TTM) N/A
GM 117.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

LION has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.20, we must say that LION is in the distress zone and has some risk of bankruptcy.
LION has a worse Altman-Z score (-0.20) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LION has a Current Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
LION's Current ratio of 0.36 is on the low side compared to the rest of the industry. LION is outperformed by 87.50% of its industry peers.
LION has a Quick Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.36, LION is doing worse than 86.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LION is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.27% yearly.
Based on estimates for the next years, LION will show a small growth in Revenue. The Revenue will grow by 4.59% on average per year.
EPS Next Y108.82%
EPS Next 2Y97.21%
EPS Next 3Y51.27%
EPS Next 5YN/A
Revenue Next Year1.1%
Revenue Next 2Y4.12%
Revenue Next 3Y4.59%
Revenue Next 5YN/A

3.3 Evolution

LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 1B 2B 3B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 58.18 indicates a quite expensive valuation of LION.
70.83% of the companies in the same industry are more expensive than LION, based on the Price/Earnings ratio.
LION's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.46.
Based on the Price/Forward Earnings ratio of 27.86, the valuation of LION can be described as expensive.
LION's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LION is cheaper than 69.44% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, LION is valued a bit cheaper.
Industry RankSector Rank
PE 58.18
Fwd PE 27.86
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

LION's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LION is cheaper than 90.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.72
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

LION's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LION's earnings are expected to grow with 51.27% in the coming years.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y97.21%
EPS Next 3Y51.27%

More info and screens

0

5. Dividend

5.1 Amount

LION does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIONSGATE STUDIOS CORP

NYSE:LION (7/21/2025, 8:16:16 PM)

After market: 6.4 0 (0%)

6.4

-0.01 (-0.16%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-22 2025-05-22/amc
Earnings (Next)08-06 2025-08-06
Inst Owners23.67%
Inst Owner Change-0.25%
Ins Owners4.39%
Ins Owner Change-1798.06%
Market Cap1.83B
Analysts80
Price Target9.18 (43.44%)
Short Float %N/A
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)303.17%
Min EPS beat(2)-20.6%
Max EPS beat(2)626.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.44%
Max Revenue beat(2)3.22%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE 58.18
Fwd PE 27.86
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.72
EPS(TTM)0.11
EY1.72%
EPS(NY)0.23
Fwd EY3.59%
FCF(TTM)-1.3
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS7.44
BVpS-3.78
TBVpS-15.29
PEG (NY)0.53
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROCE 5.25%
ROIC 4.15%
ROICexc 4.53%
ROICexgc N/A
OM 5.41%
PM (TTM) N/A
GM 117.71%
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.48
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.2
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y108.82%
EPS Next 2Y97.21%
EPS Next 3Y51.27%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1.1%
Revenue Next 2Y4.12%
Revenue Next 3Y4.59%
Revenue Next 5YN/A
EBIT growth 1Y331.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1414.8%
EBIT Next 3Y176.55%
EBIT Next 5YN/A
FCF growth 1Y-72843.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70899.5%
OCF growth 3YN/A
OCF growth 5YN/A